Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplaston Therapy in Adults With Meningioma
NCT00003483Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Jun 1998
- Primary completion
- Mar 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in meningioma, sponsored by Burzynski Research Institute. Started Jun 1998; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT00003483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003483.